ストックスクリーナーアプリを入手
6.06
3.50%
0.35
Nyxoah Sa (NYXH) 最新ニュース
Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Investors to Inquire about Securities Investigation - markets.businessinsider.com
Nyxoah Expects to Meet Final FDA Requirements for Sleep Apnea Treatment Device Approval in Q2 - MarketScreener
Nyxoah Expects Q2 Approval of Genio System from US FDA - MarketScreener
Nyxoah Provides Update on FDA Approvable Letter for Genio System - The Manila Times
Nyxoah Provides Update On FDA Approvable Letter For Genio System - MarketScreener
FDA Signals Green Light for Revolutionary Sleep Apnea TreatmentJust One Step Away - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Investors to Reach Out - markets.businessinsider.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A.NYXH - Bluefield Daily Telegraph
NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm - Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - GlobeNewswire Inc.
Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire
Oppenheimer maintains $13 target on Nyxoah shares post-FDA talks By Investing.com - Investing.com South Africa
Oppenheimer maintains $13 target on Nyxoah shares post-FDA talks - Investing.com
Nyxoah S.A. Investors: Company Investigated By The Portnoy Law Firm - menafn
HC Wainwright Comments on Nyxoah’s Q1 Earnings (NASDAQ:NYXH) - Defense World
Nyxoah S.A. Being Investigated on Behalf of Nyxoah S.A. Investors. Contact Levi & Korsinsky For Details - ACCESS Newswire
HC Wainwright Lowers Nyxoah (NASDAQ:NYXH) Price Target to $15.00 - Defense World
Nyxoah SA: A Medical Technology Company with a Big Loss - RagingBull
Nyxoah announces FDA approvable letter for Genio pre-market approval application - TipRanks
Nyxoah Says FDA Issues Approvable Letter for Genio System - MarketScreener
FDA Issues Approvable Letter For Nyxoah's Genio® System - TradingView
FDA Issues Nyxoah an Approvable Letter for its Genio® System - Yahoo Finance
Stifel Nicolaus Has Lowered Expectations for Nyxoah (NASDAQ:NYXH) Stock Price - Defense World
Stifel cuts Nyxoah stock price target to $15, maintains Buy By Investing.com - Investing.com Canada
Nyxoah SA (NYXH) Reports Q4 Loss, Lags Revenue Estimates - MSN
(NYXH) Investment Analysis - Stock Traders Daily
Stifel cuts Nyxoah stock price target to $15, maintains Buy - Investing.com
Nyxoah S.A. (NASDAQ:NYXH) Q4 2024 Earnings Call Transcript - Insider Monkey
H.C. Wainwright maintains Buy on Nyxoah shares, $17 target - Investing.com
Nyxoah SA (NYXH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic US ... By GuruFocus - Investing.com Canada
Nyxoah Reports 2024 Financial Results and U.S. Launch Plans - TipRanks
Nyxoah Sa’s Earnings Call: Efficacy and Expansion - TipRanks
Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results - The Manila Times
Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025 - The Manila Times
Critical Survey: Nyxoah (NASDAQ:NYXH) vs. PolyPid (NASDAQ:PYPD) - Defense World
Nyxoah (NYXH) to Release Quarterly Earnings on Thursday - Defense World
Transparency Notification: Vestal Point Capital’s Stake in Nyxoah - PanAsiaBiz
(NYXH) Investment Report - news.stocktradersdaily.com
Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - The Manila Times
Sleep Apnea Innovator Nyxoah Takes Center Stage at Major Healthcare Conference - StockTitan
Nyxoah (NYXH) to Release Quarterly Earnings on Tuesday - Defense World
Nyxoah (NYXH) Projected to Post Earnings on Tuesday - MarketBeat
Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) versus Nyxoah (NASDAQ:NYXH) Critical Review - Defense World
(NYXH) On The My Stocks Page - Stock Traders Daily
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East - GlobeNewswire
Revolutionary Sleep Apnea Treatment Crosses Borders: Inside Genio's Middle East Launch - StockTitan
Nyxoah Launches Genio Therapy in Middle East with First UAE Implantation - TipRanks
Nyxoah (NASDAQ:NYXH) Stock Price Up 0.6%Here's What Happened - MarketBeat
1.77%
1.53%
大文字化:
|
ボリューム (24 時間):